| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.13e-04 | 9 | 36 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.27e-04 | 15 | 36 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 3.73e-04 | 16 | 36 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | calmodulin binding | 7.56e-04 | 230 | 36 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 8.51e-04 | 24 | 36 | 2 | GO:0017075 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 3.13e-06 | 2 | 37 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.87e-05 | 4 | 37 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 1.40e-04 | 10 | 37 | 2 | GO:0099525 | |
| GeneOntologyCellularComponent | CCAAT-binding factor complex | 4.55e-05 | 6 | 37 | 2 | GO:0016602 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 6.37e-05 | 7 | 37 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 8.48e-05 | 8 | 37 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 7.53e-04 | 23 | 37 | 2 | GO:0098831 | |
| Domain | Unc-13 | 1.08e-05 | 3 | 36 | 2 | IPR027080 | |
| Domain | Munc13_dom-2 | 3.60e-05 | 5 | 36 | 2 | IPR014772 | |
| Domain | MOZ_SAS | 3.60e-05 | 5 | 36 | 2 | PF01853 | |
| Domain | Membr_traf_MHD | 3.60e-05 | 5 | 36 | 2 | PF10540 | |
| Domain | HAT_MYST-type | 3.60e-05 | 5 | 36 | 2 | IPR002717 | |
| Domain | DUF1041 | 3.60e-05 | 5 | 36 | 2 | SM01145 | |
| Domain | MHD2 | 3.60e-05 | 5 | 36 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.60e-05 | 5 | 36 | 2 | IPR019558 | |
| Domain | MYST_HAT | 3.60e-05 | 5 | 36 | 2 | PS51726 | |
| Domain | DUF1041 | 7.54e-05 | 7 | 36 | 2 | PF06292 | |
| Domain | Munc13_1 | 7.54e-05 | 7 | 36 | 2 | IPR014770 | |
| Domain | CAPS_dom | 7.54e-05 | 7 | 36 | 2 | IPR010439 | |
| Domain | MHD1 | 7.54e-05 | 7 | 36 | 2 | PS51258 | |
| Domain | H15 | 2.78e-04 | 13 | 36 | 2 | SM00526 | |
| Domain | H15 | 2.78e-04 | 13 | 36 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 3.24e-04 | 14 | 36 | 2 | IPR005818 | |
| Domain | PHD | 4.04e-04 | 75 | 36 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 4.70e-04 | 79 | 36 | 3 | IPR019787 | |
| Domain | PHD | 6.67e-04 | 89 | 36 | 3 | SM00249 | |
| Domain | Znf_PHD | 7.11e-04 | 91 | 36 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 8.06e-04 | 95 | 36 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 8.31e-04 | 96 | 36 | 3 | PS01359 | |
| Domain | - | 2.69e-03 | 40 | 36 | 2 | 3.40.630.30 | |
| Domain | Znf_FYVE_PHD | 2.82e-03 | 147 | 36 | 3 | IPR011011 | |
| Domain | Acyl_CoA_acyltransferase | 3.39e-03 | 45 | 36 | 2 | IPR016181 | |
| Domain | C1_1 | 5.39e-03 | 57 | 36 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 6.76e-03 | 64 | 36 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 6.76e-03 | 64 | 36 | 2 | PS50081 | |
| Domain | C1 | 6.96e-03 | 65 | 36 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 7.17e-03 | 66 | 36 | 2 | IPR002219 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 26667788 | ||
| Pubmed | HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes. | 1.10e-06 | 2 | 37 | 2 | 11306579 | |
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 1.10e-06 | 2 | 37 | 2 | 28426965 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 35613050 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 1.10e-06 | 2 | 37 | 2 | 30816091 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 12070347 | ||
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 1.10e-06 | 2 | 37 | 2 | 19558619 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 12871971 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 18701688 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 17561838 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 23070049 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 39505971 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 1.10e-06 | 2 | 37 | 2 | 31851910 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 1.10e-06 | 2 | 37 | 2 | 28489077 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 1.10e-06 | 2 | 37 | 2 | 11832228 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 1.10e-06 | 2 | 37 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 1.10e-06 | 2 | 37 | 2 | 22066784 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 1.10e-06 | 2 | 37 | 2 | 23229896 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 1.10e-06 | 2 | 37 | 2 | 32187536 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 27185879 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 11792326 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 1.10e-06 | 2 | 37 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 1.10e-06 | 2 | 37 | 2 | 17267576 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 22814762 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 24150941 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.53e-06 | 588 | 37 | 7 | 38580884 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.15e-06 | 608 | 37 | 7 | 36089195 | |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 3.30e-06 | 3 | 37 | 2 | 37343100 | |
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 3.30e-06 | 3 | 37 | 2 | 36754959 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 17639022 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23658173 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 23063713 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 33105896 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 22966208 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 15988013 | ||
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 6.60e-06 | 4 | 37 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 6.60e-06 | 4 | 37 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 6.60e-06 | 4 | 37 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 6.60e-06 | 4 | 37 | 2 | 28264913 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 15316024 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 21880731 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 17980166 | ||
| Pubmed | 9.50e-06 | 469 | 37 | 6 | 27634302 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 22248876 | ||
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 17182677 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 1.10e-05 | 5 | 37 | 2 | 34706221 | |
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 1.10e-05 | 5 | 37 | 2 | 33139401 | |
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 1.10e-05 | 5 | 37 | 2 | 11965546 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 32755572 | ||
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 1.10e-05 | 5 | 37 | 2 | 26575293 | |
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 1.65e-05 | 6 | 37 | 2 | 28635948 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.72e-05 | 1105 | 37 | 8 | 35748872 | |
| Pubmed | 1.88e-05 | 529 | 37 | 6 | 14621295 | ||
| Pubmed | Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. | 2.30e-05 | 7 | 37 | 2 | 18794358 | |
| Pubmed | 2.30e-05 | 7 | 37 | 2 | 15893389 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 2.30e-05 | 7 | 37 | 2 | 36398873 | |
| Pubmed | 2.31e-05 | 549 | 37 | 6 | 38280479 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.53e-05 | 330 | 37 | 5 | 33301849 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 3.07e-05 | 8 | 37 | 2 | 25609709 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.19e-05 | 182 | 37 | 4 | 32239614 | |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 4.93e-05 | 10 | 37 | 2 | 21040848 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 6.02e-05 | 11 | 37 | 2 | 34767769 | |
| Pubmed | Acetylation of HIV-1 integrase by p300 regulates viral integration. | 6.02e-05 | 11 | 37 | 2 | 16096645 | |
| Pubmed | The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones. | 6.02e-05 | 11 | 37 | 2 | 25374362 | |
| Pubmed | 6.06e-05 | 653 | 37 | 6 | 22586326 | ||
| Pubmed | 6.32e-05 | 1327 | 37 | 8 | 32694731 | ||
| Pubmed | 6.41e-05 | 971 | 37 | 7 | 33306668 | ||
| Pubmed | 7.18e-05 | 411 | 37 | 5 | 36652389 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.95e-05 | 1005 | 37 | 7 | 19615732 | |
| Pubmed | 8.53e-05 | 13 | 37 | 2 | 29285303 | ||
| Pubmed | 1.26e-04 | 242 | 37 | 4 | 34011540 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.54e-04 | 774 | 37 | 6 | 15302935 | |
| Pubmed | 1.57e-04 | 777 | 37 | 6 | 35844135 | ||
| Pubmed | 1.87e-04 | 104 | 37 | 3 | 9205841 | ||
| Pubmed | TGF-β signaling and Creb5 cooperatively regulate Fgf18 to control pharyngeal muscle development. | 2.07e-04 | 20 | 37 | 2 | 36542062 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.48e-04 | 536 | 37 | 5 | 15840001 | |
| Pubmed | 2.52e-04 | 538 | 37 | 5 | 10512203 | ||
| Pubmed | Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. | 2.62e-04 | 293 | 37 | 4 | 31741433 | |
| Pubmed | 2.99e-04 | 24 | 37 | 2 | 29871923 | ||
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 3.45e-04 | 128 | 37 | 3 | 28027390 | |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 3.52e-04 | 26 | 37 | 2 | 33298525 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 3.52e-04 | 26 | 37 | 2 | 17124501 | |
| Pubmed | 3.60e-04 | 1285 | 37 | 7 | 35914814 | ||
| Pubmed | 3.79e-04 | 323 | 37 | 4 | 24797263 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 4.15e-04 | 331 | 37 | 4 | 19490893 | |
| Pubmed | 5.02e-04 | 31 | 37 | 2 | 15217342 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 5.52e-04 | 639 | 37 | 5 | 23443559 | |
| Pubmed | 5.76e-04 | 645 | 37 | 5 | 25281560 | ||
| Pubmed | Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma. | 6.05e-04 | 34 | 37 | 2 | 32842143 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 6.26e-04 | 157 | 37 | 3 | 30686591 | |
| Pubmed | 6.79e-04 | 1429 | 37 | 7 | 35140242 | ||
| Pubmed | 7.17e-04 | 1442 | 37 | 7 | 35575683 | ||
| Pubmed | 7.76e-04 | 689 | 37 | 5 | 36543142 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.97e-04 | 394 | 37 | 4 | 27248496 | |
| Pubmed | The chromatin regulator Brpf1 regulates embryo development and cell proliferation. | 8.37e-04 | 40 | 37 | 2 | 25773539 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 8.65e-04 | 1489 | 37 | 7 | 28611215 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 9.01e-04 | 178 | 37 | 3 | 27637333 | |
| Pubmed | 9.23e-04 | 42 | 37 | 2 | 16387653 | ||
| Pubmed | 9.93e-04 | 418 | 37 | 4 | 34709266 | ||
| Interaction | CSNK1G2 interactions | 7.47e-08 | 119 | 37 | 6 | int:CSNK1G2 | |
| Interaction | SSRP1 interactions | 3.04e-06 | 685 | 37 | 9 | int:SSRP1 | |
| Interaction | RPL8 interactions | 4.84e-06 | 539 | 37 | 8 | int:RPL8 | |
| Interaction | CDK1 interactions | 9.38e-06 | 590 | 37 | 8 | int:CDK1 | |
| Interaction | ZNF330 interactions | 1.44e-05 | 446 | 37 | 7 | int:ZNF330 | |
| Interaction | PARP1 interactions | NFYB PHF14 ZC3H18 UBE2O HUWE1 CLSPN LEO1 NCAPH CEBPZ PPM1B INTS1 | 1.55e-05 | 1316 | 37 | 11 | int:PARP1 |
| Interaction | RPS19 interactions | 1.67e-05 | 639 | 37 | 8 | int:RPS19 | |
| Interaction | RPLP0 interactions | 2.11e-05 | 660 | 37 | 8 | int:RPLP0 | |
| Interaction | SRSF5 interactions | 2.13e-05 | 474 | 37 | 7 | int:SRSF5 | |
| Interaction | RPL7A interactions | 2.59e-05 | 679 | 37 | 8 | int:RPL7A | |
| Interaction | POLR1G interactions | 2.60e-05 | 489 | 37 | 7 | int:POLR1G | |
| Interaction | RPL36 interactions | 3.15e-05 | 504 | 37 | 7 | int:RPL36 | |
| Interaction | RPL13 interactions | 3.22e-05 | 700 | 37 | 8 | int:RPL13 | |
| Interaction | RPL3 interactions | 4.01e-05 | 722 | 37 | 8 | int:RPL3 | |
| Interaction | SRP14 interactions | 4.97e-05 | 366 | 37 | 6 | int:SRP14 | |
| Interaction | ZNF207 interactions | 5.00e-05 | 111 | 37 | 4 | int:ZNF207 | |
| Interaction | GNL3 interactions | 5.13e-05 | 368 | 37 | 6 | int:GNL3 | |
| Interaction | DDOST interactions | 5.69e-05 | 375 | 37 | 6 | int:DDOST | |
| Interaction | UBXN10 interactions | 6.22e-05 | 42 | 37 | 3 | int:UBXN10 | |
| Interaction | KARS1 interactions | 6.40e-05 | 383 | 37 | 6 | int:KARS1 | |
| Interaction | RPL13A interactions | 8.62e-05 | 591 | 37 | 7 | int:RPL13A | |
| Interaction | ZBTB45 interactions | 9.12e-05 | 8 | 37 | 2 | int:ZBTB45 | |
| Interaction | NHP2 interactions | 9.54e-05 | 131 | 37 | 4 | int:NHP2 | |
| Interaction | MIF interactions | 1.15e-04 | 264 | 37 | 5 | int:MIF | |
| Interaction | RPL27 interactions | 1.22e-04 | 431 | 37 | 6 | int:RPL27 | |
| Interaction | ANOS1 interactions | 1.34e-04 | 143 | 37 | 4 | int:ANOS1 | |
| Interaction | RPL22 interactions | 1.37e-04 | 440 | 37 | 6 | int:RPL22 | |
| Interaction | RPL19 interactions | 1.39e-04 | 638 | 37 | 7 | int:RPL19 | |
| Interaction | ZBTB2 interactions | 1.55e-04 | 450 | 37 | 6 | int:ZBTB2 | |
| Interaction | PRPF19 interactions | 1.55e-04 | 450 | 37 | 6 | int:PRPF19 | |
| Interaction | RPL11 interactions | 1.59e-04 | 652 | 37 | 7 | int:RPL11 | |
| Interaction | SYT2 interactions | 1.61e-04 | 150 | 37 | 4 | int:SYT2 | |
| Interaction | H1-2 interactions | 1.81e-04 | 666 | 37 | 7 | int:H1-2 | |
| Interaction | RPL30 interactions | 2.05e-04 | 474 | 37 | 6 | int:RPL30 | |
| Interaction | RPL31 interactions | 2.06e-04 | 680 | 37 | 7 | int:RPL31 | |
| Interaction | HGH1 interactions | 2.30e-04 | 65 | 37 | 3 | int:HGH1 | |
| Interaction | RPL28 interactions | 2.57e-04 | 494 | 37 | 6 | int:RPL28 | |
| Interaction | FARSB interactions | 2.66e-04 | 171 | 37 | 4 | int:FARSB | |
| Interaction | EIF4A3 interactions | 2.71e-04 | 499 | 37 | 6 | int:EIF4A3 | |
| Interaction | SRSF6 interactions | 2.83e-04 | 503 | 37 | 6 | int:SRSF6 | |
| Interaction | TBL2 interactions | 2.96e-04 | 176 | 37 | 4 | int:TBL2 | |
| Interaction | H2AC8 interactions | 3.03e-04 | 177 | 37 | 4 | int:H2AC8 | |
| Interaction | RPL18 interactions | 3.11e-04 | 512 | 37 | 6 | int:RPL18 | |
| Interaction | WDR26 interactions | 3.16e-04 | 179 | 37 | 4 | int:WDR26 | |
| Interaction | RPS9 interactions | 3.21e-04 | 515 | 37 | 6 | int:RPS9 | |
| Interaction | KPNA2 interactions | 3.34e-04 | 519 | 37 | 6 | int:KPNA2 | |
| Interaction | RPS24 interactions | 3.70e-04 | 529 | 37 | 6 | int:RPS24 | |
| Interaction | RPS14 interactions | 3.70e-04 | 529 | 37 | 6 | int:RPS14 | |
| Interaction | RPL15 interactions | 3.74e-04 | 530 | 37 | 6 | int:RPL15 | |
| Interaction | JADE1 interactions | 3.79e-04 | 77 | 37 | 3 | int:JADE1 | |
| Interaction | DIMT1 interactions | 3.88e-04 | 189 | 37 | 4 | int:DIMT1 | |
| Interaction | NAP1L1 interactions | 3.97e-04 | 345 | 37 | 5 | int:NAP1L1 | |
| Interaction | RPS27 interactions | 4.02e-04 | 346 | 37 | 5 | int:RPS27 | |
| Interaction | MRPS16 interactions | 4.04e-04 | 191 | 37 | 4 | int:MRPS16 | |
| Interaction | KDF1 interactions | 4.12e-04 | 192 | 37 | 4 | int:KDF1 | |
| Interaction | PABPN1 interactions | 4.12e-04 | 192 | 37 | 4 | int:PABPN1 | |
| Interaction | RPL4 interactions | 4.17e-04 | 764 | 37 | 7 | int:RPL4 | |
| Interaction | NAP1L4 interactions | 5.38e-04 | 206 | 37 | 4 | int:NAP1L4 | |
| Interaction | THOC3 interactions | 5.43e-04 | 87 | 37 | 3 | int:THOC3 | |
| Interaction | WDR70 interactions | 5.43e-04 | 87 | 37 | 3 | int:WDR70 | |
| Interaction | RPL23AP32 interactions | 5.43e-04 | 87 | 37 | 3 | int:RPL23AP32 | |
| Interaction | NASP interactions | 5.48e-04 | 207 | 37 | 4 | int:NASP | |
| Interaction | DOC2A interactions | 5.50e-04 | 19 | 37 | 2 | int:DOC2A | |
| Interaction | RPL17 interactions | 5.55e-04 | 571 | 37 | 6 | int:RPL17 | |
| Interaction | ABCF2 interactions | 5.68e-04 | 209 | 37 | 4 | int:ABCF2 | |
| Interaction | ZNF346 interactions | 5.94e-04 | 377 | 37 | 5 | int:ZNF346 | |
| Interaction | RPL22L1 interactions | 6.00e-04 | 90 | 37 | 3 | int:RPL22L1 | |
| Interaction | RPN1 interactions | 6.09e-04 | 814 | 37 | 7 | int:RPN1 | |
| Interaction | BRCA2 interactions | 6.46e-04 | 384 | 37 | 5 | int:BRCA2 | |
| Interaction | MKRN2 interactions | 6.53e-04 | 385 | 37 | 5 | int:MKRN2 | |
| Interaction | RBM17 interactions | 6.65e-04 | 218 | 37 | 4 | int:RBM17 | |
| Interaction | RPL37A interactions | 7.01e-04 | 391 | 37 | 5 | int:RPL37A | |
| Interaction | RPS25 interactions | 7.09e-04 | 392 | 37 | 5 | int:RPS25 | |
| Interaction | IARS1 interactions | 7.17e-04 | 393 | 37 | 5 | int:IARS1 | |
| Interaction | POLR2H interactions | 7.24e-04 | 223 | 37 | 4 | int:POLR2H | |
| Interaction | PSAT1 interactions | 7.46e-04 | 97 | 37 | 3 | int:PSAT1 | |
| Interaction | RPL24 interactions | 7.50e-04 | 397 | 37 | 5 | int:RPL24 | |
| Interaction | CCDC88A interactions | 7.61e-04 | 226 | 37 | 4 | int:CCDC88A | |
| Interaction | DGKZ interactions | 7.91e-04 | 99 | 37 | 3 | int:DGKZ | |
| Interaction | RPS15A interactions | 8.03e-04 | 403 | 37 | 5 | int:RPS15A | |
| Interaction | EXOSC3 interactions | 8.15e-04 | 100 | 37 | 3 | int:EXOSC3 | |
| Interaction | C11orf58 interactions | 8.39e-04 | 101 | 37 | 3 | int:C11orf58 | |
| Interaction | RPLP2 interactions | 8.58e-04 | 409 | 37 | 5 | int:RPLP2 | |
| Interaction | NACA interactions | 8.66e-04 | 234 | 37 | 4 | int:NACA | |
| Interaction | CDC20 interactions | 8.66e-04 | 234 | 37 | 4 | int:CDC20 | |
| Interaction | DUSP16 interactions | 9.08e-04 | 237 | 37 | 4 | int:DUSP16 | |
| Interaction | MEAF6 interactions | 9.13e-04 | 104 | 37 | 3 | int:MEAF6 | |
| Interaction | RPS6 interactions | 9.28e-04 | 874 | 37 | 7 | int:RPS6 | |
| Interaction | SAP30BP interactions | 9.39e-04 | 105 | 37 | 3 | int:SAP30BP | |
| Interaction | ELOA interactions | 9.81e-04 | 242 | 37 | 4 | int:ELOA | |
| Interaction | WWTR1 interactions | 9.87e-04 | 422 | 37 | 5 | int:WWTR1 | |
| Interaction | MAGED2 interactions | 9.96e-04 | 243 | 37 | 4 | int:MAGED2 | |
| Interaction | ABT1 interactions | 9.97e-04 | 423 | 37 | 5 | int:ABT1 | |
| Interaction | LSM14B interactions | 1.05e-03 | 109 | 37 | 3 | int:LSM14B | |
| Interaction | ILF3 interactions | 1.07e-03 | 896 | 37 | 7 | int:ILF3 | |
| Interaction | RPS5 interactions | 1.08e-03 | 431 | 37 | 5 | int:RPS5 | |
| Interaction | NIFK interactions | 1.08e-03 | 431 | 37 | 5 | int:NIFK | |
| Interaction | DHX40 interactions | 1.09e-03 | 249 | 37 | 4 | int:DHX40 | |
| Interaction | H1-4 interactions | 1.14e-03 | 656 | 37 | 6 | int:H1-4 | |
| Interaction | EIF1AY interactions | 1.20e-03 | 28 | 37 | 2 | int:EIF1AY | |
| GeneFamily | UNC13 homologs | 1.01e-05 | 4 | 24 | 2 | 836 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 2.00e-04 | 16 | 24 | 2 | 66 | |
| GeneFamily | PHD finger proteins | 2.24e-04 | 90 | 24 | 3 | 88 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.27e-04 | 17 | 24 | 2 | 486 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.35e-02 | 134 | 24 | 2 | 861 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.36e-05 | 654 | 37 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 167 | 37 | 4 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 55 | 37 | 3 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 176 | 37 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 176 | 37 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 182 | 37 | 4 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.75e-05 | 188 | 37 | 4 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 195 | 37 | 4 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.02e-05 | 195 | 37 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 195 | 37 | 4 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.23e-05 | 200 | 37 | 4 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.23e-05 | 200 | 37 | 4 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-04 | 126 | 37 | 3 | e33957cf1541733b06de9f9e7b2801b3d8ae831d | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-04 | 129 | 37 | 3 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-04 | 130 | 37 | 3 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-04 | 151 | 37 | 3 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.02e-04 | 158 | 37 | 3 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | PSB-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.37e-04 | 164 | 37 | 3 | 3e672124dea2497c5bdf8a315c8cfacfab5780dc | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-04 | 164 | 37 | 3 | d7053de88ef8e42cac6726a40e72f212659ee034 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 165 | 37 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 165 | 37 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-04 | 166 | 37 | 3 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-04 | 166 | 37 | 3 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-04 | 167 | 37 | 3 | a48349f189f6a8d563744b0a294c3974f3a18f50 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 3.56e-04 | 167 | 37 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 3.56e-04 | 167 | 37 | 3 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 169 | 37 | 3 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 169 | 37 | 3 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 169 | 37 | 3 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 169 | 37 | 3 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.81e-04 | 171 | 37 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, Lineage and Cell Type | 3.94e-04 | 173 | 37 | 3 | 226bb8d881f32d65c60f5e4c034c6d465f8e7ba5 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.94e-04 | 173 | 37 | 3 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-04 | 173 | 37 | 3 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-04 | 175 | 37 | 3 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(232)_CD4+/CD45RA+_Naive_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 4.08e-04 | 175 | 37 | 3 | fc40fda0fb9954cb0970c6ac71f6d6df7d27dc5c | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 4.08e-04 | 175 | 37 | 3 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 4.15e-04 | 176 | 37 | 3 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.29e-04 | 178 | 37 | 3 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-04 | 179 | 37 | 3 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-04 | 179 | 37 | 3 | dc0b806904ef4c2f74f34ade2b1c0d6893f3b2ec | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-04 | 180 | 37 | 3 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 4.50e-04 | 181 | 37 | 3 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-04 | 181 | 37 | 3 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-04 | 181 | 37 | 3 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.50e-04 | 181 | 37 | 3 | ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e | |
| ToppCell | IPF-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 4.57e-04 | 182 | 37 | 3 | f91bb45baaec76cb3bb26eedbcf0709b2492e93f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.65e-04 | 183 | 37 | 3 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-04 | 183 | 37 | 3 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 4.65e-04 | 183 | 37 | 3 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.72e-04 | 184 | 37 | 3 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 185 | 37 | 3 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-04 | 185 | 37 | 3 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.79e-04 | 185 | 37 | 3 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 4.87e-04 | 186 | 37 | 3 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-04 | 186 | 37 | 3 | d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.02e-04 | 188 | 37 | 3 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-04 | 188 | 37 | 3 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 5.02e-04 | 188 | 37 | 3 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.02e-04 | 188 | 37 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.10e-04 | 189 | 37 | 3 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.18e-04 | 190 | 37 | 3 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 191 | 37 | 3 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.26e-04 | 191 | 37 | 3 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-04 | 191 | 37 | 3 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 191 | 37 | 3 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 5.26e-04 | 191 | 37 | 3 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-04 | 192 | 37 | 3 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-04 | 192 | 37 | 3 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-04 | 192 | 37 | 3 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-04 | 192 | 37 | 3 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.34e-04 | 192 | 37 | 3 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.34e-04 | 192 | 37 | 3 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.42e-04 | 193 | 37 | 3 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.42e-04 | 193 | 37 | 3 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.42e-04 | 193 | 37 | 3 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-04 | 194 | 37 | 3 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-04 | 194 | 37 | 3 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.51e-04 | 194 | 37 | 3 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-04 | 194 | 37 | 3 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-04 | 194 | 37 | 3 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-04 | 194 | 37 | 3 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-04 | 194 | 37 | 3 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-04 | 194 | 37 | 3 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.51e-04 | 194 | 37 | 3 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-04 | 194 | 37 | 3 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.59e-04 | 195 | 37 | 3 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-04 | 195 | 37 | 3 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.59e-04 | 195 | 37 | 3 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-04 | 195 | 37 | 3 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 5.67e-04 | 196 | 37 | 3 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-04 | 196 | 37 | 3 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-04 | 196 | 37 | 3 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.67e-04 | 196 | 37 | 3 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 5.67e-04 | 196 | 37 | 3 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 196 | 37 | 3 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 5.67e-04 | 196 | 37 | 3 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.35e-05 | 190 | 37 | 5 | 1421_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.49e-05 | 194 | 37 | 5 | 1264_DN | |
| Disease | childhood onset asthma | 7.14e-04 | 334 | 36 | 4 | MONDO_0005405 | |
| Disease | rheumatoid arthritis, celiac disease | 7.46e-04 | 33 | 36 | 2 | EFO_0000685, EFO_0001060 | |
| Disease | mean corpuscular hemoglobin concentration | 2.02e-03 | 1105 | 36 | 6 | EFO_0004528 | |
| Disease | Malignant Glioma | 3.32e-03 | 70 | 36 | 2 | C0555198 | |
| Disease | mixed gliomas | 3.32e-03 | 70 | 36 | 2 | C0259783 | |
| Disease | atopic eczema | 3.57e-03 | 252 | 36 | 3 | EFO_0000274 | |
| Disease | Self-injurious behavior | 4.10e-03 | 78 | 36 | 2 | HP_0100716 | |
| Disease | Cleft Palate | 4.41e-03 | 81 | 36 | 2 | C0008925 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 4.74e-03 | 84 | 36 | 2 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HNDDPDSAVDDRDSD | 186 | Q9UPW8 | |
| RPHEDCENSAGEEED | 151 | Q9BYV9 | |
| DEDEVSEAQETPDHA | 796 | Q8IUX7 | |
| SANIHDGATDDAEDD | 561 | Q9UPS8 | |
| DDNDDDDDVLASDFH | 2461 | Q9Y485 | |
| FDLTPDSDSDDEDAH | 886 | Q2TAZ0 | |
| DLFDSHDDRDDDAEA | 351 | Q96SU4 | |
| HDDRDDDAEAGSVEE | 356 | Q96SU4 | |
| EEPSHNEDHDADDED | 1416 | Q8WYB5 | |
| SERSDHEDNDPSDVD | 91 | Q8WVC0 | |
| NSDDERPVASDNDDE | 211 | Q8WVC0 | |
| PQASDEEHRHSDDEE | 251 | Q8WVC0 | |
| HDAVDDAASGEEDDE | 916 | Q8N201 | |
| PHDDTEDSMNDHEDT | 31 | P25208 | |
| SDDDDDDDIPQEDHY | 2236 | Q9Y4D8 | |
| RAPTADDDDDDHDDH | 156 | Q96MY1 | |
| PRSNHAAEEASSEDE | 716 | Q7Z6Z7 | |
| NDEGNDEDHSSPASE | 251 | O94880 | |
| AETAQNDDHDADDED | 1306 | Q92794 | |
| DSDSDDDDEEHGAPL | 46 | Q9NQC8 | |
| ALPSSEDDDDDDDSS | 121 | P11362 | |
| EEAEAEDVDSPASSH | 91 | Q7Z591 | |
| DNSDDSEAPDDNSDD | 141 | Q96QF7 | |
| DNSDDSEAPDDNSDD | 151 | Q96QF7 | |
| DNSDDSEAPDDNSDD | 161 | Q96QF7 | |
| DNSDDSEAPDDNSDD | 171 | Q96QF7 | |
| DNSDDSDVPDDNSDD | 181 | Q96QF7 | |
| SQLDDHPESDDEENF | 621 | Q03701 | |
| HPESDDEENFIDAND | 626 | Q03701 | |
| RRFPDDDDESEDHDD | 381 | Q99983 | |
| DDDESEDHDDPDNAH | 386 | Q99983 | |
| PEREDSDNDDDTHVR | 1226 | O14654 | |
| DLDSHVDADDDPSTL | 471 | O14513 | |
| ENDDNSDESADSEPH | 976 | P57071 | |
| EDISNDDDDMHPAAA | 6 | Q96ME1 | |
| NPHRESDGASDEAEE | 371 | O75688 | |
| DDFDANDEPDHTAVG | 371 | Q15003 | |
| DSDEDEHSDSGNDLA | 1011 | Q9HAW4 | |
| ETEAEDPDDEAGSHS | 521 | Q969H4 | |
| DRLHSAEQDADDEAA | 471 | Q9C0C9 | |
| SFEDPDSAVDDRDSD | 176 | O14795 | |
| QADAAEAAREDHEDA | 581 | P52739 | |
| CEDFQDEDHDSASPD | 356 | Q8IUK5 | |
| DAHRGAESENEEESP | 21 | Q9UEG4 | |
| GNHSEEDSTDDQRED | 1291 | P35125 | |
| RGPSQEEEDNHSDEE | 56 | Q86VM9 | |
| HSDEEDRASEPKSQD | 66 | Q86VM9 |